Xconomy

@Xconomy

Authoritative voice on biotech's exponential economy: news, events, awards, webinars, whitepapers, , , ,

United States
Vrijeme pridruživanja: travanj 2009.

Tweetovi

Blokirali ste korisnika/cu @Xconomy

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Xconomy

  1. Prikvačeni tweet
    23. sij
    Poništi
  2. prije 54 minute
    Poništi
  3. prije 1 sat
    Poništi
  4. proslijedio/la je Tweet
    prije 1 sat

    ICYMI, won FDA approval Friday for , a peanut allergy therapy. The FDA decision covers kids 4-17 yrs.old...

    Poništi
  5. proslijedio/la je Tweet
    1. velj

    carries an $890 a month wholesale price before any rebates or discounts. But says it will offer payment assistant programs that could reduce the cost to as low as $20 a month. The new drug is expected to launch in coming weeks.

    Prikaži ovu nit
    Poništi
  6. proslijedio/la je Tweet

    Xconomy: BIO Report: More Work Needed to Improve Diversity at Biotech Firms via

    Poništi
  7. 31. sij
    Poništi
  8. proslijedio/la je Tweet
    31. sij

    When it comes to , size matters. Here's why thinks the smaller size of Cas14 gives it advantages for developing new drugs and diagnostics

    Poništi
  9. 30. sij

    [PARTNER EVENT] presents 7th annual Healthcare Investment Trends: Where Will the Money Flow in 2020? Use code HCVC-PARTNER for $25 discount on registration. REGISTER: Sponsored by

    Poništi
  10. 30. sij

    Newly added speakers include: Ciara Kennedy of Chris Loryman of Russ Barrans of Josh Schimmer of Evercore

    Poništi
  11. 30. sij
    Poništi
  12. 30. sij
    Poništi
  13. 30. sij
    Poništi
  14. 30. sij

    Spun out the where Nancy Hopkins won the Lifetime Achievement Award, 3 scientists formed the Boston Biotech Working Group to "remedy the gender imbalance in biotech":

    Poništi
  15. 30. sij
    Poništi
  16. proslijedio/la je Tweet
    30. sij

    Lack of good a factor for in investing $70-90m into internal PA gene therapy plant

    Poništi
  17. proslijedio/la je Tweet
    29. sij
    Poništi
  18. proslijedio/la je Tweet
    29. sij

    This drug didn't pan out treating a rare blood disorder or chronic kidney disease. But with positive topline Phs 2 data in , some now see blockbuster potential. shares shot up 50% Tues.

    Poništi
  19. proslijedio/la je Tweet
    29. sij

    When developing a new therapy how do you keep in complete control of its manufacturing? This whitepaper looks at what to consider - whatever path you take.

    Poništi
  20. proslijedio/la je Tweet
    29. sij

    Attend the 14th Annual Hub and SPP Model Optimization event, which will feature manufacturers, pharmacies, PBMs and more, on February 24-26, 2020, at the Loews Philadelphia Hotel. Register today!

    Poništi
  21. 29. sij
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·